Opioids
Administrative and insurance barriers continue to block access to treatment, AMA President-elect Susan R. Bailey, MD, tells Congress.
Health insurers, pharmacy benefit management companies and others are making it harder for physicians to provide appropriate care to patients living with pain.
Press Releases
Physicians and medical students acted today to strengthen existing AMA policy promoting increased access to naloxone, the opioid overdose-reversing drug.
AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.
Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment.
The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.
The AMA backs proposals the Interagency Pain Task Force discussed, a signal that policy makers understand the treatment required for patients in pain.
A new report today by the AMA, North Carolina Medical Soc, and Manatt Health shows North Carolina is adopting strategies to combat the opioid epidemic.
A new report today by the AMA, Mississippi State Medical Assn (MSMA), and Manatt Health shows Mississippi is adopting strategies to combat the opioid epidemic.
Payers, regulators and others have turned clinical advice into hard-and-fast rules that can harm patients.
